首页 | 本学科首页   官方微博 | 高级检索  
检索        

腹安灌肠液治疗危重症患儿胃肠功能障碍的临床观察
引用本文:喻康野,黄新华,李黑大,胡金平,刘惠民,罗维平,李文莉.腹安灌肠液治疗危重症患儿胃肠功能障碍的临床观察[J].中国中西医结合杂志,2002,22(4):261-263.
作者姓名:喻康野  黄新华  李黑大  胡金平  刘惠民  罗维平  李文莉
作者单位:江西省宜春市人民医院,江西,336000
基金项目:江西省宜春市科委科研基金资助项目(No.2001-6-23)
摘    要:目的:观察腹安灌肠液治疗危重症患儿胃肠功能障碍的疗效。方法:将89例危重患儿随机分为西药常规治疗组(简称对组)和西药常规加腹安灌肠液治疗组(简称治疗组),分别于入院时、伴发胃肠功能障碍时及治疗后检测血浆内皮素(ET)变化,并与健康对照组比较,同时观察患儿胃肠功能功能恢复情况和临床疗效。结果:治疗且对胃肠功能障碍总有效率为84.62%,与对照组(62.17%)比较差异有显著性(P<0.05)。治疗组52例中抢救成功34例,死亡16例,放弃治疗2例,病死率30.77%;对照组37例中抢救成功16例,死亡18例,放弃治疗3例,病死率48.65%,治疗组病死率低于对照组(x^2=4.64,P<0.05)。入院时两组血浆ET含量均高于健康对照组(P<0.01),伴发胃肠功能障碍时血浆ET比入院时明显增高(P<0.01),治疗后逐渐下降,治疗组较对照组下降明显,两组治疗后比较差异有显著性(P<0.05)。结论:危重症患儿伴发胃肠功能障碍时血浆ET明显增高,腹安灌肠液能有效降低血浆ET水平,促进危重症患儿胃肠功能恢复,对提高危重症抢救成功率起到一定的作用。

关 键 词:腹安灌肠液  治疗  危重症  胃肠功能  障碍  临床观察  儿童  血浆内皮素  中药灌肠
修稿时间:2001年10月8日

Clinical Observation on Treatment of Gastrointestinal Dysfunction by Fu′an Liquid for Retention Enema(腹安灌肠液) in Children with Critical Illness
Authors:YU Kang ye  HUANG Xin hu  LI Hei da
Abstract:OBJECTIVE: To observe the therapeutic effect of Fu'an Liquid (FAL) for retention enema in treating gastrointestinal (GI) dysfunction of children with critical illness. METHODS: Eighty-nine patients were randomly divided into two groups, 52 in the treated group and 37 in the control group. Conventional therapy of western medicine was given to both groups and to the treated group FAL was given additionally. Plasma endothelin (ET) level was measured during admission, GI dysfunction occurrence and after treatment, and the therapeutic effect as well as the recovery of GI condition were observed. RESULTS: The total effective rate of FAL in treating GI dysfunction was 84.62%, which was significantly higher than that in the control group (62.17%) (P < 0.05). In the treated group, 34 cases were treated successfully, 16 died and the other 2 abandoned, the mortality rate being 30.77%, while in the control group, the corresponding numbers were 16, 18, 3 and 48.65%. The mortality rate in the treated group was lower than that in the control group (chi 2 = 4.64, P < 0.05). Level of ET in both groups was higher than normal range during admission (P < 0.01), it further increased when GI dysfunction occurred (P < 0.01), and decreased when successfully treated, the decrease was quicker in the treated group than that in the control group (P < 0.05). CONCLUSION: In children with critical illness, ET level would increase when the patient was complicated with GI dysfunction. FAL for retention enema could reduce the ET level effectively, promote the recovery of patients from GI dysfunction, so as to play a definite role in enhancing the successful rate of rescue.
Keywords:
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号